$CTIX Headlines Cellceutix jumps on QIDP tag 1:23 p.m.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$CTIX Headlines

Cellceutix jumps on QIDP tag 1:23 p.m. Dec. 8, 2014 - Seeking Alpha
Cellceutix Brilacidin IND effective, Phase 2 to begin 9:31 a.m. Oct. 13, 2014 - Seeking Alpha
Regulatory Support Creates Opportunity For Antibiotic Makers Otonomy And Cellceutix 9:02 a.m. Sept. 25, 2014 - Seeking Alpha
Update: Cellceutix Calls Out To President Obama About Brilacidin 2:38 p.m. Sept. 21, 2014 - Seeking Alpha
10-K: CELLCEUTIX CORP 12:53 p.m. Sept. 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
Update: Cellceutix's Antibiotic Brilacidin Should Move Share Price Before Kevetrin Or Prurisol 2:06 a.m. Sept. 14, 2014 - Seeking Alpha
The Antibiotic Resistance Triple Threat 1:05 p.m. Sept. 4, 2014 - Seeking Alpha
Cellceutix completes enrollment in Brilacidin trial 8:45 a.m. Aug. 19, 2014 - Seeking Alpha
Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market? 10:38 a.m. Aug. 14, 2014 - Seeking Alpha
10-Q: CELLCEUTIX CORP 9:15 a.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Huge Opportunities Are Now Possible Due To Market Inefficiencies In Valuing Antibiotic Companies Such As Cubist, Durata, And Cellceutix 9:34 a.m. April 25, 2014 - Seeking Alpha
10-Q: CELLCEUTIX CORP 4:09 p.m. Feb. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin 9:31 a.m. Jan. 28, 2014 - Seeking Alpha
Cellceutix Corp.: A Biotech With High Risk But High Reward 3:17 p.m. Jan. 2, 2014 - Wall St. Cheat Sheet
Cellceutix: An Undiscovered Company Set To Rise In 2014 9:06 a.m. Dec. 16, 2013 - Seeking Alpha
3 Innovative Biotech Companies Poised To Shine At TAP Partnership Conference 5:38 a.m. Nov. 19, 2013 - Seeking Alpha
10-Q: CELLCEUTIX CORP 5:06 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: CELLCEUTIX CORP 3:01 p.m. Sept. 30, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: CELLCEUTIX CORP 1:18 p.m. May 20, 2013 - Edgar Online - (EDG = 10Q, 10K)
Interview with CEO of Cellceutix Corporation: Leo Ehrlich 8:57 a.m. Nov. 15, 2011 - GuruFocus.com


Cellceutix Antibiotic Brilacidin Receives QIDP Designation From FDA 7:01 a.m. Dec. 8, 2014 - Marketwired
Cellceutix: December to Be Momentous Month in Company's History 7:02 a.m. Nov. 24, 2014 - Marketwired
These Medical Stocks Are Reaching A Fever Pitch Following Midterm Elections 9:54 a.m. Nov. 12, 2014 - ACCESSWIRE
Patient Enrollment in Cellceutix Phase 2 Clinical Trial of Brilacidin-OM for Oral Mucositis Targeted to Begin in December 2014 7:01 a.m. Nov. 11, 2014 - Marketwired
Cellceutix's New Chief Operating Officer Dr. James Alexander Addresses Shareholders 6:00 a.m. Oct. 31, 2014 - Marketwired
Cellceutix Announces Positive Top-Line Data From Phase 2b ABSSSI Trial; Single-Dose Brilacidin Comparable to 7-Days of Daptomycin 10:52 a.m. Oct. 23, 2014 - Marketwired
Cellceutix Investigational New Drug (IND) Application Becomes Effective, Selects First Site for Phase 2 Clinical Trial of New Treatment for Oral Mucositis 8:02 a.m. Oct. 13, 2014 - Marketwired
Cellceutix Provides Update to Shareholders 11:30 a.m. Sept. 24, 2014 - Marketwire
Cellceutix to President Obama: We Have the Tools and Will Rise Up to the Challenge to Prevent Antibiotic Resistant Bacteria Becoming a Serious Threat to Public Health 6:15 a.m. Sept. 19, 2014 - Marketwire
Cellceutix Provides Initial Observations of Completed ABSSSI Phase 2b Trial; Company Submits Investigational New Drug Application to FDA for Phase 2 Trial of Brilacidin-OM for Oral Mucositis 2:01 p.m. Sept. 9, 2014 - Marketwire
Cellceutix to Present at Rodman & Renshaw's 16th Annual Global Investment Conference 10:17 a.m. Sept. 5, 2014 - Marketwire
Cellceutix Appoints Dr. Barry Schechter to Board of Directors as Company Focuses on Meeting Requirements for Stock Exchange Uplisting 6:01 a.m. Sept. 2, 2014 - Marketwire
Cellceutix Completes Enrollment in Phase 2b Clinical Trial of Brilacidin for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 7:31 a.m. Aug. 19, 2014 - Marketwire
Cellceutix Prepares for Phase 2 Clinical Trial of Brilacidin-OM for Oral Mucositis 6:01 a.m. Aug. 11, 2014 - Marketwire
Cellceutix Anti-Psoriasis Drug Prurisol Meets Primary Endpoint of Clinical Trial 5:04 a.m. Aug. 8, 2014 - Marketwire
Cellceutix Believes Brilacidin on Track to Help U.S. Avoid Falling Into Post-Antibiotic Era; Completion of Enrollment in Phase 2b Trial for Acute Bacterial Skin and Skin Structure Infections Expected This Month 6:01 a.m. Aug. 4, 2014 - Marketwire
Cellceutix Announces Breakthrough in the Formulation of Its Novel Antibiotic Brilacidin(TM), Plans Studies to Treat Diabetic Foot Ulcers 6:01 a.m. July 14, 2014 - Marketwire
Cellceutix Brilacidin ABSSSI Trial Gets Positive Review by Data Safety Monitoring Board; Best Possible Outcome, No Treatment-Related Serious Adverse Events (SAEs) 6:00 a.m. July 7, 2014 - Marketwire
Cellceutix Anti-Fungal Compounds Awarded $1.5 Million SBIR Grant 6:01 a.m. June 23, 2014 - Marketwire
Cellceutix Clinical Trial of Anti-Cancer Drug Kevetrin Entering Eighth Cohort 6:01 a.m. June 16, 2014 - Marketwire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sirva, Vialto Team Up for Seamless Global Relocation

Updated Category News Views 67

Shaking Up the Relocation Game Going global isn't just about stepping onto a plane anymore. Moving across borders has baggage—literally and figuratively. Sirva and Vialto Partners have teamed up to make the borderless shuffle a whole lot smoother, bringing relocation and tax expertise under one virtual roof. Navigating Complex Waters Let's face it, relocating is like...

Continue Reading
Navigating Headstone Choices Beyond Cemetery Norms

Updated Category News Views 79

Decoding Headstone Purchases: A Monumental Decision Headstones may not be on everyone's mind until they're suddenly front and center—a task during a time filled with emotions. Contrary to what many folks believe, the cemetery isn't the sole option for purchasing these memorials. The traditional route has always included cemeteries peddling everything you might need in...

Continue Reading
2026 World Laureates Forum Drives Science Forward

Updated Category News Views 44

A Meeting of Great Minds in Shanghai Alright, listen up. Shanghai's gearing up to be the nerve center for the 2026 World Laureates Forum (WLF), and it's seething with potential. This ain't your regular science fair; it's a lion's den of brainpower set to crack open the future of science and tech. With the heavy-hitters like Nobel and Turing laureates on the docket, you're...

Continue Reading
Independents Finally Center Stage on Election Night

Updated Category News Views 67

Unprecedented Spotlight on Independent Voters The political landscape is in for a shake-up, folks. Come November 3rd, we're witnessing something that hasn't been done before—an entire Election Night dedicated exclusively to independent voters. It’s high time these folks got the spotlight, considering a whopping 45% of U.S. adults have shunned the extremist seesaw of...

Continue Reading
Globe Life Faces 8% Stock Dip Amidst Legal Scrutiny

Updated Category News Views 120

Trouble Brews for Globe Life Investors Brace yourselves, folks. Globe Life Inc. (NYSE: GL) has found itself slap-bang in the middle of a potentially messy legal quagmire. The $7 million in excess Medicare Supplement claims that popped up due to a snail-like processing delay by the Centers for Medicare & Medicaid Services (CMS) have sent investors scrambling. And oh boy,...

Continue Reading
Vertiv's $1.45B Bet on Transforming Power Solutions

Updated Category News Views 77

Power Play: Vertiv's Big Move Amid the chatter of acquisitions, Vertiv's hefty $1.45 billion swoop for UtilityInnovation Group isn’t just another line in the ledger. This one’s got substance. It's one of those moves where the dollars translate directly into future-proofing in a real sense—not just padding out some exec's CV. Filling the Gaps in AI Infrastructure...

Continue Reading
SLM Hit by Earnings Miss: Shareholders Eye Legal Action

Updated Category News Views 66

When A Profit Turns To Loss There's a certain sting that comes with expecting a profit only to get smacked with a loss. You know the kind—like when SLM Corporation shareholders had their expectations shattered on October 22, 2026. They figured they'd see a $0.17 profit per share, but what landed instead was a $0.19 loss. That's a $0.36-per-share swing, enough to make...

Continue Reading
Perpetua Wins $40M U.S. Army Deal: Eyes Tungsten Boost

Updated Category News Views 81

Perpetua's Strategic Move in Mineral Exploration Forget the sleazy diner talk for a sec. We're diving into a strategic American push to revive homegrown tungsten supply. Perpetua Resources is dancing a new jig with a solid $40 million award from the U.S. Army, assisting in this military-driven goal through the Defense Ordnance Technology Consortium. Talk about a smart...

Continue Reading
Electra's Ultra Short Aircraft Revolutionizes Air Travel

Updated Category News Views 181

From Tarmacs to Heliports: A New Era in Air Travel The aviation world doesn’t often see a sea change, but when a fixed-wing flyer touches down at a heliport, it grabs your attention. Electra’s recent leap into Manhattan’s Downtown Skyport highlights a promising shift in regional air mobility, doing away with the age-old reliance on long runways. It’s a shift that...

Continue Reading
Bank of America Faces Legal Battle Over Compliance Failures

Updated Category News Views 106

Another Day, Another Lawsuit Just when you thought the financial waters were calm, there's a storm brewing for Bank of America Corp. (NYSE: BAC). They've been slapped with a securities class action lawsuit that screams all kinds of regulatory and compliance failures. You’d think with all that cash flow, BAC could afford to run a tight ship. But apparently, they decided...

Continue Reading

Top 5 Most Recently Viewed Articles

North Media Marks Preliminary Results for 2024, Insight on 2025

Updated Category News Views 318

Preliminary Financial Insights for North Media North Media has released its preliminary financial results for the year 2024, which reveal important trends and shifts in the company's operations. The results show a decrease in revenue and EBIT compared to earlier projections, primarily due to the write-down of assets related to SDR Svensk Direktreklam. Financial Overview...

Continue Reading
Unlocking the Growth Story Behind Constellation Brands Stock

Updated Category News Views 218

Constellation Brands: A Journey of Growth Constellation Brands (NYSE: STZ) has demonstrated robust performance over the past decade and a half, consistently outpacing market trends. This leading beverage company specializes in the acquisition and marketing of wine, beer, and spirits. As of now, Constellation Brands holds a market capitalization of approximately $27.92...

Continue Reading
QuidelOrtho Announces Robust Growth in Q2 2025 Earnings

Updated Category News Views 203

QuidelOrtho's Impressive Q2 2025 Performance QuidelOrtho Corporation (NASDAQ: QDEL) has revealed its financial results for the second quarter of 2025, reflecting a notable performance driven by strategic cost-cutting measures and steady demand in key segments. Key Financial Highlights During this quarter, QuidelOrtho reported total revenue amounting to $614 million, which...

Continue Reading
Prepare for Holiday Shopping: Identity Theft Protection Tips

Updated Category News Views 238

Understanding the Surge of Identity Theft During Holidays Identity theft is a serious concern for consumers, especially during the holiday shopping season. Reports indicate that identity theft cases dramatically increase in October as early holiday shopping begins. Allstate Identity Protection has unveiled alarming trends which warn shoppers to remain vigilant against...

Continue Reading
Grupo Aeroportuario del Pacífico Sees Positive Growth in Passenger Traffic

Updated Category News Views 190

Passenger Traffic Growth Report Grupo Aeroportuario del Pacífico (GAP), operating 12 airports in Mexico, recently shared its preliminary figures for terminal passenger traffic for September 2025, marking a noteworthy increase compared to the previous year. This announcement signals great developments in the travel industry, particularly for GAP, as more travelers are...

Continue Reading